Abbott: FDA clears FreeStyle Libre 2, FreeStyle Libre 3 sensors

Abbott announced that the U.S. FDA has cleared its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring system sensors for integration with automated insulin delivery systems. Abbott modified the sensors to enable integration with AID systems. The modified sensors were also cleared for use by children as young as two years old and for wear time up to 15 days. Current FreeStyle Libre 2 and FreeStyle Libre 3 sensors available today in the U.S. are approved for people four years and older and have a wear time of up to 14 days.